Guillain-Barré syndrome after surgery for Stage II lung adenocarcinoma

Patient Info: Anonymized, Male, 70+ | Stage II

No lung-cancer recurrence was seen at follow-up after complete resection. His postoperative Guillain-Barré syndrome resolved within 3 months after immunoglobulin treatment and rehabilitation.

PubMed CentralRead more →

Stage II Invasive Lobular Carcinoma: Lizzie's Survivor Story

Patient Info: Lizzie, Female | Stage II

Lizzie completed mastectomy, reconstruction-related surgery and 5 weeks of radiation. She remained on a planned 10-year course of an aromatase inhibitor and became active in breast cancer research advocacy.

Lobular Breast Cancer AllianceRead more →

Stage 2 triple-negative breast cancer: pathologic complete response to chemotherapy

Patient Info: Anonymized, Female, 40s | Stage II

Biomarkers: Triple-negative breast cancer, with pathogenic PALB2 c.1451T>A variant found in blood/buccal/tumor testing.

As of May 2024, more than 1 year after surgery, she was well and free of cancer after neoadjuvant chemotherapy, mastectomy, reconstruction, and preventive adnexectomy.

PubMed CentralRead more →

Secretory breast cancer: mastectomy and radiotherapy to no evidence of disease

Patient Info: Anonymized, Female, 60s | Stage II

Biomarkers: ER-negative; PR-negative; HER2-negative; Ki-67 50%; tumor-infiltrating lymphocytes 60%

As of May 2024, 6 months after mastectomy and adjuvant radiotherapy for pT2N0M0 triple-negative secretory breast cancer, clinical examination and imaging showed no evidence of relapse.

PubMed CentralRead more →

Stage II EGFR Non-Small Cell Lung Cancer: Daniel's Survivor Story

Patient Info: Daniel West, Male | Stage II

Biomarkers: EGFR alteration

At the latest report, Daniel had no evidence of active cancer; small lung nodules were being monitored without progression while he continued osimertinib.

Stage II Gastric Cancer: Irasema's Survivor Story

Patient Info: Irasema Partida Chavez, Female, Under 40 | Stage II

Irasema reported no evidence of stomach cancer for about 8 years after treatment for her localized recurrence.

Stage II lung adenocarcinoma with a fetal-type component treated with surgery

Patient Info: Anonymized, male, 70+ | Stage II

Biomarkers: PD-L1 negative; no alterations identified on Oncomine Dx testing

He was doing well without recurrence 8 months after surgery.

PubMed CentralRead more →

Stage II Lung Cancer: Ed's Survivor Story

Patient Info: Ed Ackerman, Male, 60s | Stage II

Follow-up tests and scans showed Ed was cancer-free after lung resection and 4 rounds of chemotherapy for Stage IIA lung cancer.

Cleveland ClinicRead more →

Stage II Colorectal Cancer: Savannah's Survivor Story

Patient Info: Savannah Kaspar, Female, Under 40 | Stage II

Biomarkers: Lynch syndrome genetic testing negative

As of March 2024, Savannah had completed partial colectomy and 4 rounds of adjuvant chemotherapy for Stage II sigmoid colon cancer and had entered surveillance with bloodwork every 3 months.

MD AndersonRead more →

Stage II HR-Positive Invasive Ductal Carcinoma: Allison's Patient Story

Patient Info: Allison Tierney, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive; CHEK2 mutation; BRCA1/2 negative

As of March 2024, Allison had completed Taxol and Herceptin treatment, was on tamoxifen planned for 10 years, and had moved to 6-month oncology follow-up. No metastatic disease or recurrence was reported.

YouTube — The Patient StoryRead more →

Stage II Colorectal Cancer: John's Survivor Story

Patient Info: John, Male, Under 40 | Stage II

As of March 2024, John had a complete response to chemotherapy and radiation for Stage II rectal cancer, with the tumor completely gone, no signs of cancer remaining, no surgery needed, and ongoing watch-and-wait monitoring.

Cleveland ClinicRead more →

Stage II Triple-Negative Breast Cancer: Chance's Survivor Story

Patient Info: Chance Osborne, Female, Under 40 | Stage II

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1 mutation

As of March 2024, Chance Osborne was a young Stage II TNBC survivor with a BRCA1 mutation, sharing her experience with chemotherapy, double mastectomy recovery, and advocacy.

Stage II HR-Positive Invasive Ductal Carcinoma: Dorian's Survivor Story

Patient Info: Dorian de Salvo, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

As of March 2024, Dorian had a complete response to TCHP chemotherapy, clear surgical margins, and no lymph-node involvement after surgery, with radiation completed and additional care still expected for several months.

The Patient StoryRead more →

Stage II lung adenocarcinoma with severe atezolizumab-related myocarditis after surgery

Patient Info: Anonymized, female, 40s | Stage II

Biomarkers: PD-L1 TPS 50%

More than 1 year after atezolizumab was discontinued, there was no recurrence of the lung cancer.

PubMed CentralRead more →

Stage II Colorectal Cancer: Allison's Survivor Story

Patient Info: Allison, Female, Under 40 | Stage II

As of March 2024, Allison was a Stage IIC rectal/colorectal cancer survivor after chemoradiation, major open surgery with temporary ileostomy and J-pouch creation, and additional chemotherapy; no metastatic disease was reported.

The Patient StoryRead more →

Stage II Colorectal Cancer: Kara's Patient Story

Patient Info: Kara Wutzke | Stage II

After chemotherapy, surgery, a temporary ileostomy, and reversal, Kara focused on gradually rebuilding her fitness, strength, and sense of self.

Fight Colorectal CancerRead more →

Stage II Colorectal Cancer: Jay's Survivor Story

Patient Info: Jay McCoy, Male, 40s | Stage II

As of January 2024, Jay had made a full recovery after Stage II colon cancer was found early by colonoscopy and treated surgically, with normal numbers at his second annual physical in June 2023.

Cleveland ClinicRead more →

HER2-positive Stage IIB breast cancer complicated by acute neuro-Behcet disease during neoadjuvant treatment

Patient Info: Anonymized, Female, 40s | Stage II

Biomarkers: ER-positive; PgR/PR-positive; HER2-positive by FISH amplification; Ki-67 index 50%

As of June 2024, there was no recurrence of breast cancer or neuro-Behcet disease 2 years after surgery and postoperative HER2-directed plus endocrine therapy.

PubMed CentralRead more →

Stage II Colorectal Adenocarcinoma: Keith's Patient Story

Patient Info: Keith | Stage II

After surgery, no lymph nodes were positive and his latest scan showed nothing of concern.

Our Cancer StoriesRead more →

Ovarian cancer chemotherapy continued after paclitaxel-related liver injury

Patient Info: Anonymized, Female, 50s | Stage II

Biomarkers: somatic BRCA1/2 negative

She completed all 6 planned chemotherapy cycles after dose reduction for liver toxicity and then entered routine surveillance.

PubMed CentralRead more →

Stage II Breast Cancer: Paula's Patient Story

Patient Info: Paula | Stage II

Paula was receiving chemotherapy and hormonal therapy for stage 2 breast cancer, with additional treatments included in the recommended plan.

Our Cancer StoriesRead more →

Stage II Colorectal Cancer: Maggie's Survivor Story

Patient Info: Maggie | Stage II

Diagnosed in September 2024 and declared cancer-free in December 2024 after surgery.

Our Cancer StoriesRead more →

Stage II Triple-Negative Breast Cancer: Chantal's Survivor Story

Patient Info: Chantal, Female, Under 40 | Stage II

Biomarkers: Triple-negative breast cancer; BRCA1 mutation

As of December 2023, Chantal reported that she did not currently have cancer, was followed by medical oncology every 3-4 months, and used Signatera testing because tumor markers were not reliable for her.

The Patient StoryRead more →

Gastric Cancer Treatment Interrupted by Capecitabine-Related Brain Toxicity

Patient Info: Anonymized, Female | Stage II

Her cognition and vital signs improved over several days after capecitabine was stopped. At follow-up 2 weeks later, chemotherapy remained suspended and the treatment plan was revised to radiation alone.

PubMed CentralRead more →